Concepedia

Noushin Brealey

NB

Statistics

Publications

16

Citations

2.1K

H-Index

14

Active since

2014

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United Kingdom)

University of Pennsylvania

GlaxoSmithKline (United States)

Age UK

Noushin Brealey is an author at Research Triangle Park Foundation specializing in clinical pharmacology, pharmacology, and pharmacotherapy.

Publications per year

2014–2022

16

Publications

16

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

, , +17

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 330 citations · Full text

, , +17

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

Steven Pascoe, David A. Lipson, Nicholas Locantore et al. · European Respiratory Journal · 2016 · 88 citations · Full text

, , +17

Therapeutic index of inhaled corticosteroids in asthma: A dose–response comparison on airway hyperresponsiveness and adrenal axis suppression

Peter T. Daley‐Yates, Noushin Brealey, Sebin Thomas et al. · British Journal of Clinical Pharmacology · 2020 · 86 citations · Full text

, , +17

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA <sup>®</sup> Dry Powder Inhaler

David Prime, Wilfried De Backer, Melanie Hamilton et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2015 · 60 citations · Full text

, , +16

1–5 of 16